Genetics of Cerebrotendinous Xanthomatosis

Area of Science:

• Genetics
• Metabolic Disorders
• Biochemistry

Background:

• Cerebrotendinous xanthomatosis (CTX) is a rare, autosomal recessive metabolic disorder.
• It stems from biallelic pathogenic variants in the CYP27A1 gene, crucial for bile acid biosynthesis.
• Deficiency leads to cholestanol accumulation and multisystemic disease, often diagnosed late.

Purpose of the Study:

• To review the medical and population genetics of CTX.
• To explore genotype-phenotype correlations and variant functional effects.
• To discuss advances in diagnostics and screening for early intervention.

Main Methods:

• Analysis of medical genetics and population genetics data.
• Review of functional and clinical data for CYP27A1 variants.
• Examination of biochemical testing and newborn screening strategies.

Main Results:

• Over 200 pathogenic CYP27A1 variants identified, with population-specific frequencies.
• Variant functional effects (complete loss-of-function vs. hypomorphic) correlate with clinical and biochemical severity.
• Underdiagnosis remains a significant issue, despite available therapies.

Conclusions:

• Stratifying CYP27A1 variants aids in understanding CTX clinical severity.
• Emerging diagnostic tools like newborn screening promise presymptomatic detection.
• Integrating diverse data improves variant interpretation, diagnosis, and therapeutic strategies for CTX.